JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

JNJ

192.08

-0.38%↓

ABT

126.36

-1.14%↓

MDT

94.19

-1.71%↓

VEEV

291.41

+0.69%↑

A

147.65

+1.19%↑

Search

Intuitive Surgical Inc

Suletud

SektorTervishoid

551.23 4.64

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

525.35

Max

552.26

Põhinäitajad

By Trading Economics

Sissetulek

-40M

664M

Müük

187M

2.4B

P/E

Sektori keskmine

62.123

37.461

Kasumimarginaal

27.221

Töötajad

15,638

EBITDA

268M

987M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+16.06% upside

Turustatistika

By TradingEconomics

Turukapital

-21B

164B

Eelmine avamishind

546.59

Eelmine sulgemishind

551.23

Uudiste sentiment

By Acuity

23%

77%

127 / 371 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bearish Evidence

Intuitive Surgical Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. okt 2025, 23:55 UTC

Kuumad aktsiad

Stocks to Watch: DraftKings, Texas Instruments, Intuitive Surgical, Pegasystems

21. okt 2025, 21:14 UTC

Tulu
Suurimad hinnamuutused turgudel

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth -- Update

21. okt 2025, 20:38 UTC

Tulu

Intuitive Surgical 3Q Profit, Sales Jump, Sees Higher da Vinci Procedure Growth

22. juuli 2025, 21:13 UTC

Tulu

Intuitive Surgical Logs Higher Profit, Revenue in 2Q

22. apr 2025, 20:55 UTC

Tulu

Intuitive Surgical Reports Higher 1Q Profit, Warns of Tariff Hit to Margins

22. okt 2025, 15:42 UTC

Tulu

Intuitive Surgical Stock Jumps on Earnings. Its Newest Surgical Robot Is Going Gangbusters. -- Barrons.com

22. okt 2025, 12:34 UTC

Tulu

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

22. okt 2025, 11:49 UTC

Tulu

Intuitive Surgical Stock Surges. Earnings Show It Can Maintain 'Bellwether Medtech Growth Status.' -- Barrons.com

21. okt 2025, 20:08 UTC

Tulu

Intuitive Surgical: Worldwide Da Vinci Procedure Growth of Approximately 17% to 17.5% in 2025, Compared to 17% in 2024 >ISRG

21. okt 2025, 20:08 UTC

Tulu

Intuitive Surgical: Non-GAAP Gross Profit Margin to Be Within a Range of 67% and 67.5% of Rev in 2025, Compared to 69.1% in 2024 >ISRG

21. okt 2025, 20:05 UTC

Tulu

Intuitive Surgical 3Q Rev $2.51B >ISRG

21. okt 2025, 20:05 UTC

Tulu

Intuitive Surgical 3Q Net $704.4M >ISRG

21. okt 2025, 20:05 UTC

Tulu

Intuitive Surgical 3Q Adj EPS $2.40 >ISRG

21. okt 2025, 20:05 UTC

Tulu

Intuitive Surgical 3Q Da Vinci Surgical Systems Shipped 427.00 >ISRG

21. okt 2025, 20:05 UTC

Tulu

Intuitive Surgical 3Q EPS $1.95 >ISRG

22. juuli 2025, 20:14 UTC

Tulu

Intuitive Surgical Sees FY25 Non-GAAP Gross Profit Margin to Be Within Range of 66% and 67% >ISRG

22. juuli 2025, 20:13 UTC

Tulu

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15.5% to 17% >ISRG

22. juuli 2025, 20:13 UTC

Tulu

Intuitive Surgical Grew Da Vinci Surgical System Installed Base to 10,488 Systems as of June 30 >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Net $658.4M >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Da Vinci Surgical Systems Shipped 395.00 >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Rev $2.44B >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q Adj EPS $2.19 >ISRG

22. juuli 2025, 20:05 UTC

Tulu

Intuitive Surgical 2Q EPS $1.81 >ISRG

22. apr 2025, 20:13 UTC

Tulu

Intuitive Surgical Sees FY25 Worldwide Da Vinci Procedure Growth of 15% to 17%

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q EPS $1.92 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Adj EPS $1.81 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Net $698.4M >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Da Vinci Surgical Systems Shipped 367.00 >ISRG

22. apr 2025, 20:05 UTC

Tulu

Intuitive Surgical 1Q Rev $2.25B >ISRG

24. jaan 2025, 21:17 UTC

Tulu

Why Intuitive Surgical Crumbled Despite Its Upbeat Fourth-Quarter Report -- IBD

Võrdlus sarnastega

Hinnamuutus

Intuitive Surgical Inc Prognoos

Hinnasiht

By TipRanks

16.06% tõus

12 kuu keskmine prognoos

Keskmine 611.68 USD  16.06%

Kõrge 685 USD

Madal 440 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Intuitive Surgical Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

20 ratings

16

Osta

3

Hoia

1

Müü

Tehniline skoor

By Trading Central

514.59 / 539.05Toetus ja vastupanu

Lühikene perspektiiv

Weak Bearish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Strong Bullish Evidence

Sentiment

By Acuity

127 / 371 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Intuitive Surgical Inc

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
help-icon Live chat